Buy CJC-1295 with DAC Peptide in Australia
Buy CJC-1295 with DAC in Australia from Macropus Peptides in 2mg, 5mg and 10mg research vials, all priced and ready to order. It is a stabilised version of the first 29 amino acids of growth hormone releasing hormone, fitted with a drug affinity complex that latches onto albumin so the signal lasts for days instead of minutes. Every vial holds lyophilised powder sealed under a crimp cap, labelled with compound, strength, lot number and storage temperature, and the certificate of analysis for that lot is available when you ask. The 10mg vial carries the lowest price per milligram, the 2mg vial suits method checks, and the 5mg vial also comes in a starter kit with water and supplies. Add bacteriostatic water, check out, and the parcel ships from inside Australia to any address in the country. CJC-1295 with DAC is sold for in-vitro laboratory research only, to buyers 18 and over, and never for human or veterinary use.
| Compound | CJC-1295 with DAC |
|---|---|
| Amount | 2 mg |
| Form | Lyophilised powder |
| Category | Growth hormone research |
| Storage | -20 °C, protect from light |
| Testing | HPLC purity 98% or higher and mass spectrometry identity, every batch |
| Certificate of analysis | Available for every lot, matched to the lot number on the label |
CJC-1295 with DAC 2mg vial
Enter the diluent volume added to this vial to see the solution concentration. Laboratory calculation only, not dosing guidance.
Buy CJC-1295 with DAC Australia: 2mg, 5mg and 10mg Vials
Macropus Peptides supplies the long-acting, albumin-binding form of this growth hormone releasing hormone (GHRH) analogue in three priced strengths: 2mg, 5mg and 10mg. It is a modified 29 amino acid GHRH fragment carrying a drug affinity complex, sold as research-grade lyophilised powder for laboratory work. All three fills come from a single specification and each lot is released separately; choosing one over another alters only the milligram content and the unit cost.
CJC-1295 with DAC Australia: what the peptide is
The hypothalamus releases GHRH to tell the pituitary when to make growth hormone. Only the first 29 of its 44 amino acids are needed for full activity, and that short chain is the starting point here. Four positions are swapped for amino acids that resist breakdown: D-alanine at position 2, glutamine at 8, alanine at 15 and leucine at 27. At the far end sits the DAC, short for drug affinity complex: an extra lysine carrying a maleimide linker that forms a covalent bond with albumin, the most plentiful protein in blood. Once attached to albumin, the analogue is shielded from enzymes and from clearance by the kidneys. It reached early human studies in the mid-2000s but was never registered as a medicine in any country, and it is now supplied as a research tool.
CJC 1295 DAC peptide Australia: how the albumin-bound analogue works in research
The analogue switches on the GHRH receptor carried by somatotrophs, the growth hormone cells of the anterior pituitary. Receptor activation lifts cyclic AMP in those cells, driving both the synthesis and the release of growth hormone, and growth hormone in turn raises IGF-1 output from the liver. Native GHRH produces a burst that fades within minutes. The albumin-bound version keeps the receptor stimulated for days, with a half-life of about six to eight days in the 2006 human data, so laboratories use it to model sustained GHRH input and to ask how the pituitary behaves when that input no longer switches off between pulses.
It is also the natural contrast to the short-acting Mod GRF 1-29. The two share the same stabilised chain, and the linker is the only structural difference. With the linker, stimulation is continuous; without it, each addition gives one short pulse and a return to baseline. Choose the DAC form when prolonged exposure, or the steady IGF-1 rise that follows it, is the variable under study, and the free form when pulsatile release is.
CJC 1295 with DAC: what the research shows
The compound was first described in Endocrinology in 2005, in rat work showing that GHRH fragments conjugated to albumin activated the pituitary receptor for far longer than the free peptide, and naming this analogue as the lead long-lasting candidate. Two human papers followed in 2006, both in the Journal of Clinical Endocrinology and Metabolism. The first measured how long the analogue stayed in circulation in healthy adults, together with growth hormone and IGF-1 levels over the following weeks. The second asked whether growth hormone still rose and fell in pulses during that continuous stimulation, and reported that pulsatile secretion persisted while baseline levels rose. That result is why the analogue remains a reference tool for separating tonic from pulsatile GHRH signalling. Each paper is summarised by design and measurement in our long-acting GHRH research studies library.
CJC-1295 DAC vial specifications
| Specification | Detail |
|---|---|
| Compound | CJC-1295 with DAC |
| Amount | 2 mg |
| Form | Lyophilised powder |
| Category | Growth hormone research |
| Storage | -20 °C, protect from light |
A freeze-dried plug of white peptide rests at the base of each glass vial, closed with a grey stopper and an aluminium crimp. The printed label carries the name, fill weight, lot reference and storage temperature. With the linker included, the molecule weighs roughly 3,650 daltons, against about 3,370 for the free 1-29 chain. Quote the lot reference and we email the matching certificate of analysis. Until the vial is opened, a freezer at -20 °C and a dark shelf keep the powder in its best condition.
CJC-1295 with DAC price in Australia: value across three fills
| Strength | Price | Price per mg |
|---|---|---|
| CJC-1295 with DAC 2mg | $94.99 | $47.49 per mg |
| CJC-1295 with DAC 5mg | $129.99 | $26.00 per mg |
| CJC-1295 with DAC 10mg | $179.99 | $18.00 per mg |
Each vial carries an Australian dollar price, and the larger the fill, the cheaper every milligram inside it. The 2mg vial is the smallest outlay but the dearest per milligram, so it suits a short method check rather than a full study. The 5mg vial is the middle step and the size built into our starter kit. The 10mg vial costs well under the price of two 5mg vials, which makes it the better buy once a protocol needs more than five milligrams on a single lot.
CJC-1295 with DAC 5mg: the entry vial and starter kit size
Five milligrams covers a pilot run or a single sustained-exposure series on one lot, and it is the fill most first orders are built around. Two millilitres of bacteriostatic water take the vial to 2.5 mg per mL, which is 250 micrograms for each tenth of a millilitre, and two and a half millilitres settle it at an even 2 mg per mL. The same vial sits in the DAC starter kit beside a 3 mL bottle of bacteriostatic water, ten 0.5 mL insulin syringes and twenty alcohol swabs, so a laboratory without supplies on hand can start from one parcel.
CJC-1295 with DAC 10mg: the lowest price per milligram
Twice the content of the smaller vial suits multi-arm designs or long time courses that must share one lot, since a lot change partway through adds a variable to the results. A 4 mL addition gives 2.5 mg per mL, lining up exactly with the 5mg vial mixed with 2 mL, so volume sheets written for the smaller fill carry across unchanged. Two millilitres make a stronger 5 mg per mL stock, and 5 mL bring it down to 2 mg per mL.
CJC-1295 with DAC 2mg: a small vial for method work
The 2mg vial is aimed at method development, where a laboratory wants to confirm handling, solubility and assay response before buying at scale, or at a single short exposure series. One millilitre of water puts it at 2 mg per mL, and two at 1 mg per mL, a round 1,000 micrograms in each millilitre that keeps later dilutions easy to log. Because the sealed powder keeps for months frozen, some groups hold a 2mg vial in reserve as a lot-matched check against a larger order.
Best place to buy CJC-1295 DAC in Australia
- Sold online at macropuspeptides.com in 2mg, 5mg and 10mg, priced from $94.99
- Every batch HPLC tested to 98% or higher purity, with identity confirmed by mass spectrometry
- A certificate of analysis for every lot, matched to the lot number printed on the label
- Same-day dispatch from Australian stock for orders paid before 2pm AEST on a business day
- Tracked delivery Australia wide: standard in 2 to 5 working days, express in 1 to 2 working days
- Payment by PayID or bank transfer, with your order ID as the reference
Ordering CJC 1295 DAC online in five steps
- Pick the 2mg, 5mg or 10mg vial
- Choose how many vials the study needs
- Add bacteriostatic water, or take the matching starter kit with water and supplies instead
- Pay at checkout after declaring you are an adult ordering for research
- Keep the lot reference so the certificate can be matched to your vials
CJC-1295 DAC calculator: how much water each fill takes
Divide the milligrams sealed in the vial by the millilitres of diluent you add, and the answer is the stock strength. Two milligrams: one millilitre makes 2 mg per mL and two make 1. Five milligrams: one millilitre makes 5 mg per mL, two make 2.5 and two and a half make 2. Ten milligrams: two millilitres make 5 mg per mL, four make 2.5 and five make 2. Multiplying by 1,000 converts to micrograms, so a 2.5 mg per mL stock holds 2,500 micrograms in each millilitre and 25 in each hundredth of one. Bottles of bacteriostatic water are stocked at 3, 10 and 30 millilitres, while syringes and swabs sit in lab supplies and kits.
Is CJC-1295 with DAC available in Australia
Yes, as a research peptide. No medicine containing this analogue is registered on the ARTG and it has no TGA approval, so it cannot be sold for use in humans or animals, and we supply it as an in-vitro research material only. Its clinical development overseas never reached registration either, so no approval is pending here. Growth hormone releasing factors and their analogues sit in the Poisons Standard, and each revision can shift the wording, so a laboratory buying the DAC form should check its own obligations first.
CJC-1295 DAC for sale Australia wide: delivery from local stock
Each parcel leaves our Australian shelves bound for laboratories in Perth, Sydney, Canberra, Hobart, Brisbane, Adelaide, Darwin, Melbourne and the regions, so no overseas freight or customs clearance stands between order and bench. Laboratories building a two-receptor design often add Ipamorelin, which works through the ghrelin receptor, and the growth hormone research range also lists the full-length GHRH analogue Tesamorelin.
References
- hGRF1-29-albumin bioconjugates activate the GRF receptor on the anterior pituitary in rats: identification of CJC-1295 as a long-lasting GRF analog. Endocrinology. 2005.
- Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. Journal of Clinical Endocrinology and Metabolism. 2006.
- Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog. Journal of Clinical Endocrinology and Metabolism. 2006.
Scientific content compiled from the peer-reviewed literature above by the Macropus Peptides technical team. Information is provided for research reference only.